FOXP3 and type 1 diabetes mellitus: Patients with T1D experience loss of Treg differentiation and function furthering disease progression [178,179], including reduced IL-2 sensitivity, unstable FOXP3 expression, and increased apoptosis [180,181,182,183,184].